Confronting Cancer as a Community

Recruiting at 1 trial location

Overseen By Ashley Noriega

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Southern California

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

500 Participants Needed

Trial Summary

What is the purpose of this trial?

This study aims to better understand the cause of colorectal cancer and how to find the best treatment for Hispanic patients with colorectal cancer. The genetic information in the blood and tissues may explain why patients who have the same type of cancer and receive the same treatment do not always have the same results. By combining genetic (certain qualities or traits passed from parents to offspring) information with clinical data, such as the responses of different kinds of cancers to different treatments, this study could lead to more knowledge about why certain cancers occur and why they respond differently to treatments. Information gathered from this study may help researchers match treatments to the genetics of each patient and the genetic changes in their tumor. This approach is known as personalized medicine.

Research Team

Heinz-Josef Lenz, MD

Principal Investigator

University of Southern California

Eligibility Criteria

Inclusion Criteria

You have been diagnosed with either colon or rectal cancer at any time in your life, regardless of the stage.

You have or intend to retain a tumor tissue specimen from an accepted medical protocol.

You are at least 18 years old.

Treatment Details

Participant Groups

Group I: Observational (stool, blood, tissue, genetic testing, questionnaires) Experimental Treatment 5 Interventions

Patients undergo stool sample collection, blood sample collection, collection of archival tumor tissue and genetic testing, and complete questionnaires on study. Patients also have their medical records reviewed on study.

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials

956

Recruited

1,609,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+